longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HeartBeam

BEAT

0.35985.07% ( -0.0192 )
Closed: Sep 25, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.00, above the reasonable range, cheaper than 0.13% of the time in the past 3 years, and the industry ranks 83/175, the industry Median -0.77.

-0.999xP/E
$0.36Stock price
$-0.36Earnings per share
-0.999xP/E
Stock price$0.36Earnings per share$-0.36

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-2.92x
Typical range
-3.76x–-2.20x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.37x141.71%$12.08B
GKOSUSGlaukos
-48.44x75.37%$9.11B
TFXUSTeleflex
-5.01x118.39%$5.17B
PLSEUSPulse Biosciences
-46.00x27.55%$3.68B
IRTCUSIRhythm
-260.88x71.96%$3.64B
AXGNUSAxogen
-75.88x30.51%$2.55B
BFLYUSButterfly Network
-33.41x34.41%$2.50B
ASSTUSStrive
-2.09x63.23%$2.04B
NVCRUSNovocure
-12.42x2.52%$1.84B
KMTSUSKestra Medical Tech
-10.61x0.94%$1.59B
ATECUSAlphatec
-14.21x41.67%$1.56B
DRTSUSAlpha Tau Medical
-14.50x--$1.34B
IARTUSIntegra LifeSciences
-173.23x109.50%$1.25B
BBNXUSBeta Bionics
-15.52x13.59%$1.13B
AORTUSArtivion
-345.77x266.67%$1.10B
TNDMUSTandem Diabetes
-17.28x77.75%$1.09B
ENOVUSEnovis
-0.97x100.97%$1.06B
PRCTUSPROCEPT BioRobotics
-8.98x3.47%$985.11M
CBLLUSCeribell
-13.78x35.15%$909.18M
SIBNUSSI-BONE
-56.94x8.85%$833.18M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.